Latest China News

Whitehaven Coal reported a 29% drop in underlying net profit to $227 million for FY26, despite record safety outcomes and successful debt refinancing that lowered funding costs and extended maturities.

Breville Group delivered record FY26 revenue of AUD 1.81 billion and EBIT of AUD 207 million, navigating tariff volatility and currency headwinds while completing a major manufacturing diversification.

BCI Minerals edges closer to first salt shipment at its Mardie Project, with crystallisation underway and 85% construction complete. The company maintains full funding and advances its sulphate of potash opportunity alongside robust sustainability initiatives.

Xenitra’s Hong Kong subsidiary Fukang has inked a three-year A$5 million procurement framework for specialised medical nutrition products, broadening its foothold beyond OTC medicines in China’s booming healthcare market.

Brazilian Rare Earths (ASX: BRE) has unveiled a scoping study for its Monte Alto and Camaçari project in Bahia, Brazil, showcasing ultra-high grades and robust economics with a post-tax NPV8 of US$6 billion and a rapid 1.1-year payback.

WAM Leaders Limited (ASX:WLE) delivered a stellar FY2026 with net profit after tax soaring 153.5% to AUD 161.8 million, driven by a 14% investment portfolio gain that outpaced the ASX 200 by 7.9%. The company declared a fully franked full year dividend of 9.6 cents per share, maintaining a strong yield amid ongoing capital raising.

Almonty Industries launches a US$300 million share repurchase program over three years, aiming to capitalise on undervalued shares ahead of full capacity at its Sangdong mine.

Chariot Resources has inked a binding term sheet with major Chinese and Nigerian partners for a phased drilling and trial mining program targeting lithium direct shipping ore in Nigeria, aiming to validate resource potential and establish a market-linked offtake.

OD6 Metals consolidates progress across its rare earths, copper, and fluorspar assets with strong resource bases and ongoing development activities in Nevada, Western Australia, and New South Wales.

Lark Distilling Co. Ltd grew net sales by 15% in FY26, driven by whisky and international expansion, but posted a $40 million loss after goodwill and inventory impairments.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.